Self-driving cars, virtual assistants, and chatbots – Artificial intelligence (AI) is no longer a vague futuristic vision but a profound disrupter to all industries. With the launch of GPT-4, the latest technology of the OpenAI family, the discussion about the transformative potential of AI has become ubiquitous.
Within the public health community, the enthusiasm and concerns about these new technologies are manifold. While AI can play an essential role in improving diagnostics, streamlining clinical practice, and making healthcare accessible for everyone, questions about patient data, biased algorithms, and misinformation arise. In this context, how do leading companies, life science organizations, and academic institutions navigate this transformation to stay on top of the curve, and where are the limitations of these new technologies when it comes to real-life implementation? The transformative power of AI has enormous potential to improve the health and well-being of people. Yet, it also comes with unprecedented challenges that need to be anticipated in new policies.
“The AI Revolution” on May 26 will shed light on the promises and perils of AI in public health. AI expert Dr. Andrew Beam, Assistant Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, will talk about artificial intelligence in public health in this 60-minute remote session for business leaders. He will focus on answering some basics about GPT4 – what is it? What isn’t it? How it works? And the ensuing conversation will focus on attendee questions and discussion, including the use of quantitative, data-driven methods in healthcare to improve, streamline, and automate decision-making.
May 26, 2023
12:00–1:00 pm ET
Fee: This session is free. Space is limited to 30 participants to allow personal discussion and focus on participants’ questions. Chatham House Rules.
Register here: https://bit.ly/AIRevolutionPublicHealth
Program
Opening remarks
Michelle A. Williams
Michelle Williams, ScD, is Dean of the Faculty at the Harvard T.H. Chan School of Public Health and Angelopoulos Professor in Public Health and International Development at the Harvard Chan School and Harvard Kennedy School. Read Michelle’s full bio here.
Guest Speaker
Andrew Beam
Andrew Beam , PhD, is an assistant professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, with secondary appointments in the Department of Biomedical Informatics at Harvard Medical School and the Department of Newborn Medicine at Brigham and Women’s Hospital. . Read Andrew’s full bio here.
Moderation & Closing Remarks
Joseph G. Allen
Joseph Allen, DSc, MPH, is associate professor of exposure assessment science at the Harvard T.H. Chan School of Public Health. In addition, he is the director of the school’s Public Health and Business Leadership and the Healthy Buildings Program. Read Joe’s full bio here.
